{
  "trial_id": "NCT03597360",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Males or females with severe AD dementia (MMSE<12) between the ages of 70 to 90 years.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Meet the criteria of AD (NIA-AA).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "If on any of the following medications: acetylcholinesterase inhibitors and/or memantine, participants must be on a stable dose for at least 60 days.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Clinically stable for at least 3 months.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Current or past history of malignancy.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Previous history of radiotherapy.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Neurological disorder other than AD.",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Currently receiving other experimental treatments.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Clinical or imaging evidence of stroke (with more than 1-2 lacunar infarcts on CT scan or MRI).",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Major depression, bipolar affective disorder or psychosis.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has MDD and is currently receiving anti-depressants. However, she still experiences symptoms of sadness and loss of interest in daily activities.",
  "_meta": {
    "topic_id": "70",
    "trial_id": "NCT03597360",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}